Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
Journal of pharmaceutical sciences, 2021-12, Vol.110 (12), p.3851-3861
2021
Volltextzugriff (PDF)

Details

Autor(en) / Beteiligte
Titel
Dual Responsive Hybrid Nanoparticle for Tumor Chemotherapy Combined with Photothermal Therapy
Ist Teil von
  • Journal of pharmaceutical sciences, 2021-12, Vol.110 (12), p.3851-3861
Ort / Verlag
United States: Elsevier Inc
Erscheinungsjahr
2021
Quelle
MEDLINE
Beschreibungen/Notizen
  • With the deepening of tumor targeting research, the application of intelligent responsive drug carriers in the field of controlled drug release has become more and more extensive, and multiple responsive nano drug carriers have attracted greater attention. In this paper, nanoparticles with gold nanorods (GNR) as the core, mesoporous silica (mSiO2) doped with hydroxyapatite (HAP) as the inorganic hybrid shell and physically loaded with doxorubicin hydrochloride (DOX·HCl) are prepared (DOX/GNR/mSiO2/HAP, DNPs). DNPs nanoparticles have a typical core-shell structure. The gold nanorods as the core have extremely high light-to-heat conversion efficiency. Under the irradiation of near-infrared light, light can be converted into heat. The inorganic hybrid shell is a drug reservoir. The excellent photothermal response of gold nanorods combined with the excellent pH response of hydroxyapatite can obtain slow and sustained release of chemotherapeutic drugs. In vivo and in vitro anti-tumor cell activity study show that the DNPs in the laser showed stronger cytotoxicity than the other groups. Compared to chemotherapy and phototherapy alone, DNPs selectively accumulate in the tumor through the enhanced penetration and retention (EPR) effects. and have the unified function of hyperthermia and chemotherapy, and have significant inhibitory effect on tumor growth. Therefore, this study provides a new idea for the study of the combination of multiple therapeutic methods in the treatment of cancer.
Sprache
Englisch
Identifikatoren
ISSN: 0022-3549
eISSN: 1520-6017
DOI: 10.1016/j.xphs.2021.08.034
Titel-ID: cdi_proquest_miscellaneous_2569380939

Weiterführende Literatur

Empfehlungen zum selben Thema automatisch vorgeschlagen von bX